Kyung J Kwon-Chung
Overview
Explore the profile of Kyung J Kwon-Chung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
4440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Czech M, Cuellar-Rodriguez J, Kwon-Chung K, Stock F, Aneke C, Olivier K, et al.
J Clin Microbiol
. 2025 Mar;
:e0155024.
PMID: 40052805
Reduced susceptibility to antifungals is common among members of genera and , with optimal treatments still not fully defined. antifungal susceptibility results and clinical data do not comprehensively account for...
2.
Ueno K, Nagamori A, Honkyu N, Kwon-Chung K, Miyazaki Y
Mucosal Immunol
. 2025 Feb;
PMID: 39984054
Lung-resident memory T cells (lung TRMs) settle in the lung and respond rapidly to external antigens, and are therefore considered to have great potential for development of respiratory vaccines. Here,...
3.
Delma F, Yang D, Cabrera-Orefice A, Coolen J, Al-Hatmi A, Ahmed S, et al.
NPJ Antimicrob Resist
. 2025 Jan;
2(1):24.
PMID: 39843955
Cryptococcal meningitis is a high-mortality infection. Adding 5-fluorocytosine (5-FC) to its treatment improves outcomes, but resistance to 5-FC presents a significant challenge. We conducted whole-genome sequencing on seven C. neoformans...
4.
Li N, Bowling J, de Hoog S, Aneke C, Youn J, Shahegh S, et al.
mBio
. 2024 Jul;
15(8):e0014424.
PMID: 38953355
Dimorphism is known among the etiologic agents of endemic mycoses as well as in filamentous . Under appropriate thermal conditions, mononuclear yeast forms alternate with multi-nucleate hyphae. Here, we describe...
5.
Chang Y, Davis M, Kwon-Chung K
J Fungi (Basel)
. 2024 Apr;
10(4).
PMID: 38667967
Flow cytometry is commonly employed for ploidy determination and cell cycle analysis in cryptococci. The cells are subjected to fixation and staining with DNA-binding fluorescent dyes, most commonly with propidium...
6.
de Hoog S, Walsh T, Ahmed S, Alastruey-Izquierdo A, Alexander B, Arendrup M, et al.
J Clin Microbiol
. 2024 Mar;
62(4):e0162523.
PMID: 38441056
No abstract available.
7.
de Hoog S, Walsh T, Ahmed S, Alastruey-Izquierdo A, Alexander B, Arendrup M, et al.
J Clin Microbiol
. 2023 Oct;
61(11):e0087323.
PMID: 37882528
The rapid pace of name changes of medically important fungi is creating challenges for clinical laboratories and clinicians involved in patient care. We describe two sources of name change which...
8.
Ueno K, Nagamori A, Honkyu N, Kataoka M, Shimizu K, Chang Y, et al.
Med Mycol
. 2023 Oct;
61(10).
PMID: 37818721
Cryptococcus neoformans is the primary causative agent of cryptococcosis. Since C. neoformans thrives in environments and its optimal growth temperature is 25-30°C, it needs to adapt to heat stress in...
9.
Yang D, Khanal Lamichhane A, Kwon-Chung K, Chang Y
mBio
. 2023 Jan;
14(1):e0345122.
PMID: 36656038
Flucytosine (5-FC) is an antifungal agent commonly used for treatment of cryptococcosis and several other systemic mycoses. In fungi, cytosine permease and cytosine deaminase are known major players in flucytosine...
10.
Drummond R, Desai J, Hsu A, Oikonomou V, Vinh D, Acklin J, et al.
J Clin Invest
. 2022 Nov;
132(22).
PMID: 36377664
Subcutaneous phaeohyphomycosis typically affects immunocompetent individuals following traumatic inoculation. Severe or disseminated infection can occur in CARD9 deficiency or after transplantation, but the mechanisms protecting against phaeohyphomycosis remain unclear. We...